Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.27)
# 1,052
Out of 4,984 analysts
454
Total ratings
42.98%
Success rate
3.77%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNTH Dianthus Therapeutics | Reiterates: Buy | $40 | $38.88 | +2.88% | 7 | Sep 8, 2025 | |
| PSNL Personalis | Reiterates: Buy | $8.5 | $5.73 | +48.34% | 17 | Sep 8, 2025 | |
| CLGN CollPlant Biotechnologies | Reiterates: Buy | $11 | $2.62 | +319.85% | 12 | Aug 21, 2025 | |
| PGEN Precigen | Reiterates: Buy | $8.5 | $3.82 | +122.51% | 13 | Aug 19, 2025 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $5 | $2.21 | +126.24% | 10 | Aug 19, 2025 | |
| CELC Celcuity | Maintains: Buy | $50 → $66 | $54.60 | +20.88% | 9 | Aug 18, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $6.92 | +189.02% | 2 | Aug 18, 2025 | |
| AEMD Aethlon Medical | Reiterates: Neutral | $1.5 | $0.75 | +98.94% | 2 | Aug 14, 2025 | |
| VOR Vor Biopharma | Reiterates: Buy | $3 | $1.52 | +97.37% | 14 | Aug 14, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $7 → $3.5 | $3.04 | +15.13% | 17 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.53 | +96.08% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $80 | $73.14 | +9.38% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $31 | $11.20 | +176.79% | 14 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $130 | $78.64 | +65.31% | 4 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.32 | +430.30% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $17.63 | +98.53% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $90 | $4.04 | +2,127.72% | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $16.71 | +85.52% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.26 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.22 | +145.90% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.05 | +90.48% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $75.18 | +92.87% | 22 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $60 | $3.90 | +1,438.46% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 → $11 | $2.05 | +436.59% | 16 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $2.93 | +378.63% | 12 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $2.10 | +66.67% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.40 | +691.67% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.31 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.55 | +174.51% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.00 | +8,900.00% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.92 | +408.65% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.55 | +2,269.24% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $23.46 | +198.38% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $30.02 | +99.87% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $6.92 | +376.88% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.24 | +1,966.12% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.00 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.94 | +58.50% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.20 | +525.00% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.47 | +64.53% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.40 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.35 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.50 | +500.00% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $2.15 | +1,062.79% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.04 | +145.10% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $5.06 | +2,271.54% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.91 | +529.92% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.68 | +2,853.34% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.27 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $5.79 | +3.63% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.91 | +685.34% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $9.44 | +249.58% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $14.70 | -35.37% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.70 | +823,429.41% | 1 | Mar 5, 2020 |
Dianthus Therapeutics
Sep 8, 2025
Reiterates: Buy
Price Target: $40
Current: $38.88
Upside: +2.88%
Personalis
Sep 8, 2025
Reiterates: Buy
Price Target: $8.5
Current: $5.73
Upside: +48.34%
CollPlant Biotechnologies
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $2.62
Upside: +319.85%
Precigen
Aug 19, 2025
Reiterates: Buy
Price Target: $8.5
Current: $3.82
Upside: +122.51%
Pyxis Oncology
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $2.21
Upside: +126.24%
Celcuity
Aug 18, 2025
Maintains: Buy
Price Target: $50 → $66
Current: $54.60
Upside: +20.88%
Actuate Therapeutics
Aug 18, 2025
Reiterates: Buy
Price Target: $20
Current: $6.92
Upside: +189.02%
Aethlon Medical
Aug 14, 2025
Reiterates: Neutral
Price Target: $1.5
Current: $0.75
Upside: +98.94%
Vor Biopharma
Aug 14, 2025
Reiterates: Buy
Price Target: $3
Current: $1.52
Upside: +97.37%
X4 Pharmaceuticals
Aug 13, 2025
Maintains: Buy
Price Target: $7 → $3.5
Current: $3.04
Upside: +15.13%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.53
Upside: +96.08%
Aug 7, 2025
Maintains: Buy
Price Target: $73 → $80
Current: $73.14
Upside: +9.38%
Aug 7, 2025
Maintains: Buy
Price Target: $29 → $31
Current: $11.20
Upside: +176.79%
Jun 24, 2025
Maintains: Buy
Price Target: $110 → $130
Current: $78.64
Upside: +65.31%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.32
Upside: +430.30%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $17.63
Upside: +98.53%
May 27, 2025
Assumes: Buy
Price Target: $90
Current: $4.04
Upside: +2,127.72%
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $16.71
Upside: +85.52%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.26
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.22
Upside: +145.90%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.05
Upside: +90.48%
May 6, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $75.18
Upside: +92.87%
May 6, 2025
Maintains: Buy
Price Target: $135 → $60
Current: $3.90
Upside: +1,438.46%
Apr 24, 2025
Reiterates: Buy
Price Target: $12 → $11
Current: $2.05
Upside: +436.59%
Apr 2, 2025
Reiterates: Buy
Price Target: $14
Current: $2.93
Upside: +378.63%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $2.10
Upside: +66.67%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.40
Upside: +691.67%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.31
Upside: -
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.55
Upside: +174.51%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.00
Upside: +8,900.00%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $4.92
Upside: +408.65%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $0.55
Upside: +2,269.24%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $23.46
Upside: +198.38%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $30.02
Upside: +99.87%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $6.92
Upside: +376.88%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.24
Upside: +1,966.12%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.00
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $6.94
Upside: +58.50%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $3.20
Upside: +525.00%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.47
Upside: +64.53%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.40
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.35
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.50
Upside: +500.00%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $2.15
Upside: +1,062.79%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.04
Upside: +145.10%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $5.06
Upside: +2,271.54%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.91
Upside: +529.92%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.68
Upside: +2,853.34%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $16.27
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $5.79
Upside: +3.63%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.91
Upside: +685.34%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $9.44
Upside: +249.58%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $14.70
Upside: -35.37%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.70
Upside: +823,429.41%